Evidence map›Paper›PMID 36101869›Full record

ArticlePsychiatric research and clinical practice2020

Increases in Suicide Deaths Among Adolescents and Young Adults Following US Food and Drug Administration Antidepressant Boxed Warnings and Declines in Depression Care.

Christine Y Lu, Robert B Penfold, Jamie Wallace, Caitlin Lupton, Anne M Libby, Stephen B Soumerai

Open access · goldAbstract read
In one paragraph

Article in Psychiatric research and clinical practice, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.8field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Suicide mortality rates in Japan before and beyond the COVID-19 pandemic era.PCN reports : psychiatry and clinical neurosciences · 2024
    Review
  5. Temporal Fluctuations of Suicide Mortality in Japan from 2009 to 2023 Using Government Databases.European journal of investigation in health, psychology and education · 2024
    Article
  6. Article
  7. Black Box Warning Did Not Cause Increased Suicides.Psychiatric research and clinical practice · 2021
    Article
  8. Response to "Black Box Warning Did Not Cause Increased Suicides".Psychiatric research and clinical practice · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Christine Y LuHarvard Medical School Department of Population Medicine and Harvard Pilgrim Health Care Institute Boston Massachusetts.
Robert B PenfoldDepartment of Health Services Research Kaiser Permanente Washington Health Research Institute and University of Washington Seattle, Washington.
Jamie WallaceHarvard Medical School Department of Population Medicine and Harvard Pilgrim Health Care Institute Boston Massachusetts.
Caitlin LuptonHarvard Medical School Department of Population Medicine and Harvard Pilgrim Health Care Institute Boston Massachusetts.
Anne M LibbyDepartment of Emergency Medicine, School of Medicine University of Colorado, Anschutz Medical Campus Denver, Colorado.
Stephen B SoumeraiHarvard Medical School Department of Population Medicine and Harvard Pilgrim Health Care Institute Boston Massachusetts.
Harvard University · USHarvard Pilgrim Health Care · USKaiser Permanente Washington Health Research Institute · US

Funding

SSRI's and SuicidalityU19MH092201 · NIMH · KAISER FOUNDATION RESEARCH INSTITUTE · PI SIMON, GREGORY E. · 2010 to 2018
$19.5M
NIMH NIH HHS U19 MH092201
6 · The paper itself

Abstract

Objective: Studies show decreased depression diagnosis, psychotherapy, and medications and increased suicide attempts following US Food and Drug Administration antidepressant warnings regarding suicidality risk among youth. Effects on care spilled over to older adults. This study investigated whether suicide deaths increased following the warnings and declines in depression care. Methods: We conducted an interrupted time series study of validated death data (1990-2017) to estimate changes in trends of US suicide deaths per 100,000 adolescents (ages 10-19) and young adults (ages 20-24) after the warnings, controlling for baseline trends. Results: Before the warnings (1990-2002), suicide deaths decreased markedly. After the warnings (2005-2017) and abrupt declines in treatment, this downward trend reversed. There was an immediate increase of 0.49 suicides per 100,000 adolescents, 95% confidence interval [CI]: 0.12, 0.86) and a trend increase of 0.03 suicides per 100,000 adolescents per year (95% CI: 0.026, 0.031). Similarly, there was an immediate increase of 2.07 suicides per 100,000 young adults (95% CI: 1.04, 3.10) and a trend increase of 0.05 suicides per 100,000 young adults per year (95% CI: 0.04, 0.06). Assuming baseline trends continued, there may have been 5958 excess suicides nationally by 2010 among yearly cohorts of 43 million adolescents and 21 million young adults. Conclusions: We observed increases in suicide deaths among youth following the warnings and declines in depression care. Alternative explanations were explored, including substance use, economic recessions, smart phone use, and unintentional injury deaths. Additional factors may have contributed to continued increases in youth suicide during the last decade. Combined with previous research on declining treatment, these results call for re-evaluation of the antidepressant warnings.

Identifiers

PMID36101869
PMCPMC9175924
OpenAlexW3092520956

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.